Background: Meconium aspiration syndrome (MAS) is respiratory distress in an infant born through meconium stained amniotic fluid (MSAF) whose signs cannot be otherwise explained. MAS is associated with different complications. Many studies have been conducted in developed world to find the outcome associated with MAS but data from developing countries is lacking. Present study was conducted to determine the impact of chemical pneumonitis, pulmonary hypertension (PHN) and air leak on outcome of new-borns with MAS.
Methods: This cross sectional descriptive study was conducted in a tertiary care Neonatology unit. The babies diagnosed with MAS were included in the study. All patients were monitored for development of complications. Outcome in terms of mortality was recorded. Outcome was compared by chisquare test and p-value <0.05 is considered significant.
Results: Seventy two babies were included in the study. Mean gestation was 37±0.56 weeks and birth weight was 2.87±0.49 kg. Male to female ratio was 1.57:1 and mean age of admission was 9.59±5.27 hours. Chemical pneumonitis, PHN and chemical pneumonitis with PHN were observed in 23.6%, 20.8% and 26.4% neonates respectively. Mortality rate was 19.44%. The mortality was highest in babies having chemical pneumonitis with PHN (p-value=0.013) followed by chemical pneumonitis group (p-value=0.02) and PHN group (p-value=0.032).
Conclusions: About three fourth babies with MAS developed one or more complications. Mortality is significantly increases with the development of complications so as more the complications more is the mortality.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Determinants of neonatal mortality among hospitalised neonates with sepsis at Queen Elizabeth Central Hospital, Blantyre, Malawi: A mixed-methods study.
PLOS Glob Public Health
December 2024
Department of Health Systems and Policy, Kamuzu University of Health Sciences, Blantyre, Malawi.
Article Synopsis
- The study focuses on neonatal sepsis mortality in Malawi, highlighting the significant health challenge it poses, especially in low-resource settings.
- Researchers utilized both quantitative and qualitative methods to identify risk factors contributing to these deaths and to examine the health system's role in the outcomes.
- Key findings indicated that factors such as gestation age and duration of hospital stay were critical predictors, alongside maternal behaviors and health system limitations that hinder timely treatment and care for affected neonates.
Management and Follow-Up of a Cohort of Neonates With Meconium Aspiration Syndrome Before and After the Revision of the 2015 Neonatal Resuscitation Program.
Cureus
November 2024
Neonatology Department, Unidade Local de Saúde (ULS) de Coimbra, Coimbra, PRT.
Article Synopsis
- - Meconium aspiration syndrome (MAS) is a serious respiratory issue in newborns that can lead to long-term health problems, prompting updates in care standards, particularly the 2015 Neonatal Resuscitation Program (NRP) to improve outcomes.
- - A 15-year study analyzed outcomes for MAS patients before and after the revised NRP, finding increased use of positive pressure ventilation in delivery rooms, but no significant changes in overall morbidity or clinical outcomes, except for improved acidosis and reduced hyperlactatemia.
- - While the updated NRP did not negatively affect clinical outcomes, challenges like cerebral palsy and global development delays remain prevalent, highlighting the ongoing impact of MAS on health even after interventions.
Treprostinil Use in the NICU.
Adv Neonatal Care
December 2024
Author's Affiliation: University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.
Background: Treprostinil is a prostacyclin analogue that is frequently used in the pediatric and adult population to treat pulmonary hypertension; however, it is not often a drug of choice for patients in the neonatal intensive care unit (NICU).
Purpose: To evaluate the efficacy of treprostinil as a treatment for pulmonary hypertension of the neonate.
Data Sources: Electronic databases such as PubMed, CINAHL, and Embase were used for this literature review.
High-Flow Oscillatory Ventilation: A Possible Therapeutic Option for Pediatric Patients with Cardiovascular Diseases.
Pediatr Rep
October 2024
Department of Anesthesia and Intensive Care 1, Azienda Ospedaliero Universitaria Policlinico, G. Rodolico-San Marco, 95123 Catania, Italy.
Article Synopsis
- High-flow oscillatory ventilation (HFOV) is a vital rescue treatment for infants and children experiencing respiratory failure from various conditions but poses risks for those with congenital heart diseases.
- HFOV operates by delivering small tidal volumes at high frequencies, which can manipulate essential hemodynamic parameters, potentially endangering congenital heart patients.
- Recent studies suggest that HFOV may not significantly impact these hemodynamic factors and can be beneficial for pediatric patients with congenital heart issues, leading to a re-evaluation of its use in this population.
The Care of Preterm and Term Newborns with Respiratory Conditions: A Systematic Synthesis of Evidence from Low- and Middle-Income Countries.
Neonatology
November 2024
Centre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada.
Introduction: Neonatal respiratory conditions are leading causes of mortality and morbidity during the neonatal period. This review evaluated 11 management interventions for respiratory distress syndrome (RDS), apnoea of prematurity (AOP), meconium aspiration syndrome (MAS), transient tachypnea of the newborn (TTN), as well as bronchopulmonary dysplasia (BPD) as a potential complication from respiratory care in low- and middle-income countries (LMICs).
Methods: Two different methodological approaches were completed: (1) updating outdated reviews and pooling all LMIC studies and (2) re-analysis of LMIC studies from up-to-date reviews.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!